Malignant renal epithelioid angiomyolipoma with an inferior vena cava and right atrium thrombus  by Lee, Hsiang-Ying et al.
at SciVerse ScienceDirect
Urological Science 23 (2012) 133e136Contents lists availableUrological Science
journal homepage: www.urol-sci .comCase report
Malignant renal epithelioid angiomyolipoma with an inferior vena cava and right
atrium thrombus
Hsiang-Ying Lee a, Chien-Wei Huang b, Ching-Chia Li c, Wen-ChengWud, Ti-Chang Liu e, Chun-ChiehWu f,
Yueh-Feng Tsai a, Yung-Shun Juan a,d,g,*
aDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
bDepartment of Cardiovascular Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
cDepartment of Urology, Kaohsiung Municipal Da-Tung Hospital, Kaohsiung, Taiwan
dDepartment of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
eDepartment of Hematology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
fDepartment of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
gDepartment of Urology, Faculty of Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwana r t i c l e i n f o
Article history:
Received 14 March 2011
Received in revised form
1 June 2011
Accepted 6 July 2011
Available online 27 November 2012
Keywords:
epithelioid angiomyolipoma
malignant angiomyolipoma* Corresponding author. Department of Urology, K
Hospital, 100, Shih-Chuan 1st Road, Kaohsiung City 8
E-mail address: juanuro@gmail.com (Y.-S. Juan).
1879-5226 Copyright  2012, Taiwan Urological Asso
http://dx.doi.org/10.1016/j.urols.2012.10.009a b s t r a c t
The epithelioid variant type of angiomyolipomas presents malignant characteristics compared to classic
angiomyolipomas. Epithelioid angiomyolipomas (eAMLomas) are easy to misdiagnose as renal cell
carcinoma due to similar histologic and radiographic ﬁndings. Until recently, only a few cases of distant
metastases of eAMLoma were reported. Herein, we describe a 69-year-old woman with renal eAMLoma
and tumor thrombus metastasis to the renal vein, inferior vena cava, and right atrium. She received a left
radical nephrectomy combined with tumor thrombus excision and systemic chemotherapy. Using this
case, we remind readers of the aggressive behavior and poor prognosis of eAMLomas and review the
literature on the optimal treatment strategy.
Copyright  2012, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Conventionally, angiomyolipomas (AMLs) are benign renal
tumors composed of adipose tissues, smooth muscle, and thick-
walled vascular elements. However, some rare cases of an epithe-
lioid variant of AMLs are highly cellular with no or minimal
amounts of fat tissues, and this variant is thought to have a more-
aggressive, malignant behavior.1 According to recent articles, this
epithelioid variant of angiomyolipomas (eAMLoma) can speciﬁcally
be divided into typical and atypical types, and the atypical type has
virtual malignant potential.2 Clinically, eAMLomas are easy to
misdiagnose as renal cell carcinoma (RCC) due to similar clinical
presentations and radiological ﬁndings.3 Epithelioid cells present
peculiar immunoreactivity, which offers physicians information for
a further differential diagnosis. Only a very small number of atyp-
ical eAMLoma cases, especially those with local or distant metas-
tases, were reported. Herein, we report a case of an eAMLoma
involving a 69-year-old womanwith an inferior vena cava and rightaohsiung Medical University
07, Taiwan.
ciation. Published by Elsevier Taiwatrium thrombus. We further discuss the pathologic ﬁndings,
treatment strategies, and prognosis of the disease.2. Case report
A 69-year-old woman experienced vague left ﬂank pain for
about 2 months. No other lower urinary tract symptoms were
noted in the beginning. She visited our emergency department, and
a urine analysis showed microscopic hematuria (10e25 red blood
cells/high-power ﬁeld). She underwent an abdominal computed
tomography (CT) examination that revealed a left renal tumor with
a tumor thrombus extending to the left renal vein inferior vena cava
and right atrium (Figs. 1 and 2). She had no family history of
malignancy or genetic disorders. According to the malignant
behavior of the imaging ﬁndings, RCC was initially considered.
A left radical nephrectomy and right atrium and inferior vena cava
tumor thrombus excision were performed. Grossly, the kidney
tumor showed several hemorrhages and focal necrosis (Fig. 3).
Microscopically, the tumor cells were various sizes and exhibited
large atypical cells with vesicular nuclei and eosinophilic cyto-
plasm. Multinucleated giant cells and atypical mitotic ﬁgures were
commonly encountered (Fig. 4). An immunohistochemical study
revealed positive staining for human melanoma black (HMB)-45,an LLC. Open access under CC BY-NC-ND license.
Fig. 1. Abdominal computed tomography coronal view with postcontrast enhance-
ment showed an inﬁltrative and heterogeneous renal tumor (white arrow) located in
the left upper to middle portion of the kidney with a dilated inferior vena cava and
tumor thrombus (black arrow).
Fig. 3. Gross appearance of the epithelioid angiomyolipoma. The gross cut surface
shows hemorrhage and focal necrosis of the tumor.
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(Fig. 5), but it was negative staining for cytokeratin, epithelial
membrane antigen (EMA), and CD-10. Follow-up abdominal CT 3
months after the operation showed local tumor recurrence in the
left renal fossa and a tumor thrombus in the inferior vena cava. She
received further systemic chemotherapy with a combination of
dacarbazine, epirubicin, ifosfamide, and mesna. Unfortunately,Fig. 2. Abdominal computed tomography transverse view postcontrast revealed
a dilated left renal vein with a tumor thrombosis (arrow).acute hepatitis and acute renal failure developed shortly after
initiation of systemic chemotherapy. She died from pneumonia,
septic shock, and respiratory failure 2 months after starting
chemotherapy.
3. Discussion
Typical AMLs are benign tumors of the kidney characterized by
a mixture of adipose tissue, smooth muscle, and thick-walled
vascular elements. Typical AMLs occur as part of the tuberous
sclerosis complex (TSC) as eAMLomas. The percentage of eAMLo-
mas associated with the TSC is higher than that for typical AMLs.4
Because of its fat component, the preferred diagnostic method for
AMLs is CT.5 The fat contexture presents as hypodensity on CT and
a hyperechoic signal on sonography.6 However, atypical variants of
eAMLoma present with different characteristics other than typical
AMLs, which may potentially be malignant. eAMLomas predomi-
nantly consist of epithelioid cells with minimal or no fat or vascular
tissues. Due to their peculiar characteristics, eAMLomas resemble
conventional RCC histologically and radiographically and have
similar cytologic features on ﬁne-needle aspiration.7 eAMLomas
and RCC both frequently present with vague ﬂank pain, a palpable
mass, or hematuria8; however, some cases are asymptomatic and
were noted as incidental ﬁndings on ultrasonography or CT. TheFig. 4. Polygonal neoplastic cells with pleomorphic nuclei, atypical mitosis (black
arrows), and numerous multinucleated giant cells (white arrow; 400).
Fig. 5. Immunohistochemical result of human melanoma black-45 showing positive
staining of neoplastic cells (200).
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and lungs.4 Involvement of lymph nodes andmetastasis to the renal
vein, inferior vena cava, and right atrium as in our case are very
rare.
Therefore, clinicians must keep in mind the possibility of an
eAMLoma on CT scans with a slight fat component, especially in
patients with the TSC. In addition, eAMLomas are possibly adjacent
to or even within a typical AML. The deﬁnitive method for the
differential diagnosis between eAMLomas and RCC is based on
immunohistochemical markers. RCCs are immunoreactive for
cytokeratin and EMA, which are negative in eAMLomas.3 By
contrast, eAMLomas stain positive for melanoma markers such as
HMB-45 and melan-A, and smooth muscle cell markers such as
SMA and caldesmon, which are not found in RCC.9 Although no
histologic parameters were developed for correlations with clinical
prognoses, Brimo et al divided eAMLomas into typical and atypical
types. The pathologic features predicting the malignant potential
included: (1) nuclear atypia in 70% of epithelioid cells; (2)
a mitotic count of 2/10 high-power ﬁelds; (3) the presence of
atypical mitotic ﬁgures; and (4) focal necrosis. The presence of at
least three of the above predicted factors increased the risk of
clinically malignant behavior.2 In our case, the pathologic features
matched all parameters, which predicted a high clinical malignancy
potential. In a recent article by Nalan et al, they proposed risk
stratiﬁcation of eAMLomas. The ﬁve adverse prognostic parameters
included the presence of the TSC and/or a concurrent angiomyoli-
poma, necrosis, a tumor size of >7 cm, extrarenal extension and/or
renal vein involvement, and a carcinoma-like growth pattern. It
divided tumors into low (no or one parameter), intermediate (two
or three parameters), and high risk (four or ﬁve parameters). This
can be used to help predict prognoses in the future.10
At present, surgical resection is still considered the ﬁrst choice
of treatment. For tumor thrombus metastasis to renal vessels, the
inferior vena cava, and even the right atrium, a thrombectomy is
reasonable. By contrast to conventional RCC, eAMLomas are
sensitive to chemotherapy because they are part of the perivascular
epithelioid cell tumor family. 11 Chemotherapy reagents, including
doxorubicin, dacarbazine, ifosfamide, cyclophosphamide, and
cisplatin, were reported in other cases.11 However, their long-term
efﬁcacy remains unclear due to the rare incidence of eAMLomas. In
our hospital, six cases of renal eAMLoma were treated in the most
recent 10 years. This is the only casewith a distant tumor thrombus,
which showed a very aggressive character. The remaining ﬁve casesdid not present tumor thrombus, distal metastasis, or lymph node
adenopathy, and the prognoses after a radical or partial nephrec-
tomy were very good.9 Further exploration of effective chemo-
therapeutic regimens with less systemic side-effects and close
follow-up after surgery are important.9 In addition to chemo-
therapy, mTORC1 inhibitors such as sirolimus and temsirolimus are
also considered as alternative adjuvant therapy. Some reports dis-
cussed their efﬁcacy with exciting positive results.12 Due to the
small amount of cases, further experience and research onmTORC1
inhibitor treatment are needed.
In addition to the kidneys, some rare cases of eAMLomaswere in
the liver, uterus, ovaries, bones, and bladder; however, they usually
occur in the liver.13 Similar to renal eAMLomas, they present
malignant behavior, and surgical excision is still the main treat-
ment. The effect and choices of chemotherapy and radiotherapy
still need to be conﬁrmed. However, there are apparent differences
between renal and extrarenal eAMLomas. Renal eAMLomas are
frequently associated with the TSC and positive immunohisto-
chemical reactivity to HMB-45, while extrarenal eAMLomas, except
for liver eAMLomas, rarely positively stain for HMB-45.13 In hepatic
eAMLomas, tumor size, p53 immunoreactivity, and proliferation
activity may predict malignant characteristics.14
eAMLomas are a rare entity of the atypical type of AMLs, which
present malignant characteristics and poor prognoses. The diag-
nosis depends on an immunohistochemical study. As shown in the
present case, surgical resection is the treatment of choice.
Chemotherapy after the operation is often considered as adjuvant
therapy because eAMLomas are chemosensitive. mTORC1 inhibi-
tors may play a role in the treatment in the future after further
investigations conﬁrm their efﬁcacy.
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